Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA-210 (miR-210) is a highly conserved, small non-coding RNA molecule that regulates gene expression post-transcriptionally. It is strongly induced by hypoxia and plays a central role in cellular responses to low oxygen levels. miR-210 influences a variety of biological processes including mitochondrial metabolism, angiogenesis, cell proliferation, and apoptosis. Dysregulation of miR-210 is implicated in diseases such as cancer and cardiovascular diseases.
miRNAs guide the RNA-induced silencing complex (RISC) to complementary sequences on target mRNAs—primarily within their 3′ untranslated regions (UTRs)—to inhibit translation or promote degradation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA-210 (miR-210).